Physical Poster + E-Poster Presentation 34th Lorne Cancer Conference 2022

Predictive biomarkers of recurrence may not be useful for deescalating treatment of breast ductal carcinoma in situ due to de novo ipsilateral breast carcinoma development (#148)

Tanjina Kader 1 , Sakshi Mahale 1 , Magnus Zethoven 1 , Hugo Saunders 1 , Dorothea Lesche 1 , David Byrne 1 , Maree Pechlevanis 1 , Olivia Craig 1 , Lauren Tjouka 1 , Jia-Min Pang 1 , Lisa Devereux 1 , Eloise House 2 , Shona Hendry 2 , Sureshni Jayasinghe 2 , Michael Toss 3 , Islam Miligy 3 , Emad Rakha 3 , Stephen Fox 1 , Bruce Mann 4 , Ian Campbell 1 , Kylie Gorringe 1
  1. Peter MacCallum Cancer Centre, Parkville, VIC, Australia
  2. Anatomical Pathology, St Vincent's Hospital, Melbourne, VIC, Australia
  3. Histopathology, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, United Kingdom
  4. The Breast Service, The Royal Women's Hospital, Melbourne, VIC, Australia
Publish consent withheld